The drama continued Monday with senior FDA leaders as more details emerged about former Center for Drug Evaluation and ...
The resignation of head drug regulator George Tidmarsh comes amid concerns about conduct related to the lupus nephritis drug ...
Less than 24 hours after resigning his post as the FDA’s head drug regulator, George Tidmarsh is reportedly reconsidering his decision and vowing to fight for his name and credibility amid a probe ...
Dr. George Tidmarsh, the FDA's top drug regulator, was placed on leave amid controversy over the drug approval process and a ...
A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...
The FDA's top drug regulator, Dr. George Tidmarsh, quit after federal officials began reviewing "serious concerns about his ...
An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...
The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.
Dr. George Tidmarsh, the Food and Drug Administration’s top drug regulator, was placed on administrative leave and is considering resigning, citing a “toxic” environment at the FDA.
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
George Tidmarsh, the FDA's top drug regulator, has been placed on leave after being accused of abusing his regulatory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback